Bloomberg's Berens on Health-Care Law, Drug Costs

Bloomberg's Berens on Health-Care Law, Drug Costs Play

Sept. 10 (Bloomberg) -- Andrew Berens, pharmaceuticals analyst for Bloomberg Industries, talks about the outlook for drug costs and U.S. health-care law. Berens speaks with Tom Keene and Sara Eisen on Bloomberg Television's "Surveillance." (Source: Bloomberg)

  • On Air Now

    Bloomberg Surveillance Watch Now

  • Next

    In The Loop with Betty Liu

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus